e-learning
resources
Munich 2006
Wednesday 06.09.2006
COPD - assessment and prognosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Evaluation of COPD longitudinally to identify predictive surrogate endpoints (ECLIPSE)
J. Vestbo, C. Harvey, D. Ffyona, L. David, M. William, S. Edwin, on Behalf of the ECLIPSE Investigators (Copenhagen, Denmark; Vancouver, Canada; London, Cambridge, Edinburgh, United Kingdom; Boston, United States Of America)
Source:
Annual Congress 2006 - COPD - assessment and prognosis
Session:
COPD - assessment and prognosis
Session type:
Electronic Poster Discussion
Number:
4679
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Vestbo, C. Harvey, D. Ffyona, L. David, M. William, S. Edwin, on Behalf of the ECLIPSE Investigators (Copenhagen, Denmark; Vancouver, Canada; London, Cambridge, Edinburgh, United Kingdom; Boston, United States Of America). Evaluation of COPD longitudinally to identify predictive surrogate endpoints (ECLIPSE). Eur Respir J 2006; 28: Suppl. 50, 4679
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Imaging of complicated pneumonia: what is new?
A 62-year-old man with scanty mucoid sputum
Related content which might interest you:
Blood biomarkers in COPD: results from the ECLIPSE (evaluation of COPD longitudinally to identify predictive surrogate endpoints) cohort
Source: Annual Congress 2009 - Biomarkers, comorbidities and prognosis of COPD
Year: 2009
SGRQ-C distribution in the evaluation of COPD longitudinally to identify predictive surrogate endpoints (ECLIPSE) cohort: Characteristics of COPD subjects with extreme score quintiles
Source: Annual Congress 2010 - COPD: symptoms and staging
Year: 2010
External validation of two prognostic scores predicting exacerbations in ECLIPSE COPD patients
Source: Virtual Congress 2020 – Airflow obstruction, COPD and comorbidities
Year: 2020
COPD related fatigue (COPD-RF) as a patient centred outcome tool in COPD: Various predictors and its correlation with other outcome parameters
Source: International Congress 2016 – Monitoring airway diseases with clinical tools
Year: 2016
Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE)
Source: Eur Respir J 2008; 31: 869-873
Year: 2008
Mortality risk prediction in COPD by a prognostic biomarker panel – Results of a derivation and validation cohort with a long term follow-up
Source: International Congress 2014 – Markers
Year: 2014
Novel patterns of serum biomarkers profiling using minimal important clinical outcomes (MICO) in the longidutinal study BODE cohort of COPD patients
Source: Annual Congress 2010 - COPD: symptoms and staging
Year: 2010
LATE-BREAKING ABSTRACT: Biomarkers of tissue turnover are related to annual change in FEV1 in patients with COPD within the ECLIPSE cohort
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015
Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohort
Source: Eur Respir J 2013; 42: 636-646
Year: 2013
Heterogeneity in the clinical outcomes of COPD: lessons from the ECLIPSE study
Source: International Congress 2017 – Heterogeneity in COPD inflammation: implications for therapy and clinical outcomes
Year: 2017
LATE-BREAKING ABSTRACT: Biomarkers of extracellular matrix turnover predict mortality in the ECLIPSE COPD cohort
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015
Identification of distinct trajectories of FEV1 progression in the ECLIPSE cohort
Source: Virtual Congress 2021 – Deep phenotyping of obstructive diseases for precision medicine
Year: 2021
Prognostic value of clinically important deterioration in COPD: IMPACT trial analysis
Source: ERJ Open Res, 7 (1) 00663-2020; 10.1183/23120541.00663-2020
Year: 2021
Possible cut-off values for stable or instable COPD as measured by the clinical COPD questionnaire (CCQ)
Source: Annual Congress 2011 - Quality of life and respiratory symptom management in primary care
Year: 2011
Predictive value of multiorgan imaging biomarkers for predicting exacerbations in COPD patients
Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Year: 2018
CAT (COPD assessment test) as outcome parameter of pulmonary rehabilitation (PR) in COPD
Source: Annual Congress 2011 - What do individuals know about their disease? Educational needs, the psychological impact of chronic respiratory disease and health-related quality of life
Year: 2011
Longitudinal change of COPD assessment test (CAT) in a telehealthcare cohort is associated with exacerbation risk
Source: International Congress 2017 – Current challenges in COPD evaluation
Year: 2017
Clinical prognostic tools and their use in COPD.
Source: Virtual Congress 2020 – Clinical and functional evaluation of COPD
Year: 2020
FEV
6
: a useful outcome measure of lung function in COPD as assessed in a large clinical study with roflumilast
Source: Eur Respir J 2004; 24: Suppl. 48, 342s
Year: 2004
Stability of serum biomarkers and their associations with clinical outcomes in COPD patients and controls: a longitudinal study
Source: Annual Congress 2009 - Biomarkers and biology in COPD
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept